awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35820168-34997045-65E0-45E2-A998-E2E785712A26
Q35820168-34997045-65E0-45E2-A998-E2E785712A26
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35820168-34997045-65E0-45E2-A998-E2E785712A26
Patterns of resource utilization and cost for postmenopausal women with hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer in Europe
P2860
Q35820168-34997045-65E0-45E2-A998-E2E785712A26
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35820168-34997045-65E0-45E2-A998-E2E785712A26
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a379b2edcae2e05f6c61ddb1b9758ef8fa260959
P2860
Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.